A Phase 1, Open-label, Single Oral Dose Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Cadazolid in Patients With Severe Clostridium Difficile Infection (CDI)
Latest Information Update: 15 Oct 2016
At a glance
- Drugs Cadazolid (Primary)
- Indications Clostridium difficile infections
- Focus Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 18 Feb 2014 New trial record